Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
ID: 353124Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353124

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-24-164.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity for the establishment of Developmental AIDS Research Centers (D-ARCs) through the P30 Clinical Trial Optional grant program. This initiative aims to support innovative interdisciplinary research at the intersection of mental health and HIV/AIDS, providing essential infrastructure to advance significant scientific discoveries in these fields. The program is particularly focused on addressing systemic health disparities in HIV treatment and prevention, encouraging collaboration among diverse organizations, including higher education institutions and nonprofits. Interested applicants can apply for grants of up to $750,000 per year for a maximum of four years, with proposals due starting July 25, 2024, and a letter of intent required 30 days prior to submission. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-24-164.html
    The National Institutes of Health's (NIH) National Institute of Mental Health (NIMH) has announced a funding opportunity (PAR-24-164) to establish Developmental AIDS Research Centers (D-ARCs), focusing on innovative interdisciplinary research at the intersection of mental health and HIV/AIDS. The funding aims to provide critical infrastructure that fosters significant advancements in HIV/AIDS and mental health research. Applications are invited for Center Core grants (P30), with a budget of up to $750,000 per year for up to four years. The program encourages collaboration with a diverse range of organizations, including institutions of higher education and nonprofits. It aims to address systemic health disparities within HIV treatment and prevention through research aligned with the National HIV/AIDS Strategy. Key areas of focus include behavioral science, implementation strategies, and data science techniques to enhance HIV care and prevention. The timeline for proposals starts with submission due dates opening on July 25, 2024, with a letter of intent required 30 days prior. The initiative emphasizes rigorous evaluation of scientific merit, innovative approaches, and engagement with the community to ensure that research aligns with public health needs and leads to impactful outcomes in reducing disparities in HIV/AIDS care.
    Similar Opportunities
    AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the AIDS Research Center on Mental Health and HIV/AIDS through the P30 Clinical Trial Optional grant program. This initiative aims to support interdisciplinary research and provide essential infrastructure for advancing high-impact science related to HIV/AIDS and mental health, aligning with the mission of the National Institute of Mental Health (NIMH). The program is significant for addressing public health concerns, promoting equitable treatment access, and minimizing health disparities in HIV treatment and prevention. Eligible applicants can receive funding of up to $1.5 million per year for projects lasting up to five years, with applications due by August 25, 2026. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-24-165.html.
    Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Funding Opportunity Announcement (FOA) for the Developmental Centers for AIDS Research (D-CFAR) program, aimed at enhancing HIV/AIDS research through administrative support and shared resources. This initiative invites applications from eligible institutions to establish D-CFARs that will foster interdisciplinary collaboration and address gaps in research infrastructure, with a focus on supporting early career investigators. Each institution may submit one application, with potential awards totaling up to $1 million annually for a duration of five years, and applications are due by August 4, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-23-117.html.
    Limited Competition: Revision Applications of Existing NIH Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) Grants (P30 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for revision applications from currently funded Centers for AIDS Research (CFAR) and Developmental CFARs (D-CFAR) to enhance their support for outreach and research related to HIV and health disparities. The initiative aims to diversify and support the next generation of HIV/AIDS investigators by requiring applicants to submit a Plan for Enhancing Diverse Perspectives (PEDP), which will be a critical component of the application review process. This funding is vital for fostering innovative research and training programs that address key barriers in HIV research, particularly for underrepresented groups. The maximum award amount is $1.5 million annually, with applications due by October 9, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-080.html.
    Centers for AIDS Research (P30 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the Centers for AIDS Research (CFAR) program, aimed at enhancing interdisciplinary HIV/AIDS research through grants. This initiative seeks to provide administrative and shared research support, fostering collaboration and infrastructure at institutions with significant NIH-funded research bases. CFARs are expected to deliver core facilities and expertise, promoting diversity, equity, and inclusion among researchers while addressing the global HIV/AIDS epidemic. Interested applicants must submit their proposals by August 4, 2025, and can find additional information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through its National Institute on Deafness and Other Communication Disorders (NIDCD), has announced a funding opportunity titled "Advancing HIV/AIDS Research within the Mission of the NIDCD (R21 Clinical Trial Optional)." This grant aims to stimulate innovative research addressing critical issues related to communication disorders—such as hearing, balance, taste, smell, voice, speech, and language—specifically for individuals living with HIV/AIDS. The initiative encourages multidisciplinary collaborations and supports low-risk clinical trials that do not require FDA oversight, with a total funding limit of $275,000 for two-year projects, and no more than $200,000 in any single year. Interested applicants, including various academic institutions and nonprofits, must submit their proposals by January 7, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services," aimed at supporting innovative research in integrated care models for HIV/AIDS and substance use disorders. The initiative seeks to improve health outcomes and enhance care coordination for individuals at heightened risk by addressing service delivery gaps through collaborative and evidence-based practices. This grant, with a funding ceiling of $450,000 over three years, is open to a diverse range of eligible applicants, including higher education institutions and community-based organizations, with applications due by March 19, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-25-020.html.
    Novel Preclinical Models of NeuroHIV in the cART Era (R61/R33 - Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Novel Preclinical Models of NeuroHIV in the cART Era" (Funding Opportunity Number: RFA-NS-24-035) aimed at developing innovative small animal models and human cellular systems that accurately reflect the interactions between the central nervous system (CNS) and the immune system in individuals living with HIV. This initiative seeks applications that propose the development and early-stage validation of next-generation humanized models to address cognitive and neurological impairments associated with chronic HIV infection, particularly in the context of antiretroviral therapy (ART). The total funding available for this initiative is approximately $6 million, with applications due by December 2, 2024. Interested applicants can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)" to stimulate research aligned with the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This initiative aims to support research on HIV-related comorbidities, gastrointestinal diseases, and metabolic disorders associated with HIV, encouraging applications from a diverse range of organizations, including higher education institutions and non-profits. With an estimated funding of $2 million for fiscal year 2025, the NIH plans to support 3 to 5 selected projects over a maximum project period of five years, with applications undergoing a rigorous peer review process. Interested applicants can find more information and submit their proposals through Grants.gov, with a submission deadline of January 7, 2025. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional) to enhance research on substance use, addiction, and HIV through collaborative efforts among investigators. This program aims to integrate diverse new and early career researchers, particularly from underrepresented backgrounds, to develop innovative approaches and interdisciplinary projects that transform the scientific research landscape. Eligible applicants include higher education institutions, nonprofits, for-profit organizations, and government entities, with a maximum project period of five years and a requirement to submit a Plan for Enhancing Diverse Perspectives (PEDP) as part of the application. Interested parties should note that the application deadline is November 17, 2025, and can find more information at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional)" aimed at stimulating research related to communication disorders associated with HIV/AIDS. This initiative encourages innovative, hypothesis-driven research that addresses high-priority areas such as hearing, speech, and language, with a focus on low-risk clinical trials that do not require FDA oversight. Eligible applicants include a wide range of organizations, such as higher education institutions and community-based organizations, with funding available up to $499,999 per year for projects lasting up to five years. Interested parties should submit their applications by January 7, 2026, and can find more information by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the announcement page at https://grants.nih.gov/grants/guide/pa-files/PAR-23-099.html.